GROUP ONE TRADING LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is and the CUSIP is 60468T955. A total of 4 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$31,918,875
+923.4%
543,300
+658.8%
0.08%
+740.0%
Q3 2023$3,118,896
+8.0%
71,600
-10.4%
0.01%
+11.1%
Q2 2023$2,886,787
+57.2%
79,900
+61.7%
0.01%
+28.6%
Q1 2023$1,836,692
-66.6%
49,400
-59.3%
0.01%
-46.2%
Q4 2022$5,496,103
+65.0%
121,300
+154.3%
0.01%
+85.7%
Q3 2022$3,331,000
+28.2%
47,700
+23.3%
0.01%
+75.0%
Q2 2022$2,598,000
-14.6%
38,700
+4.6%
0.00%
+33.3%
Q1 2022$3,042,000
-9.8%
37,000
+60.9%
0.00%0.0%
Q4 2021$3,374,000
-18.1%
23,000
-1.3%
0.00%
-25.0%
Q3 2021$4,122,000
+67.9%
23,300
+53.3%
0.00%
+33.3%
Q2 2021$2,455,000
+198.7%
15,200
+216.7%
0.00%
+200.0%
Q1 2021$822,000
-93.5%
4,800
-91.7%
0.00%
-95.5%
Q4 2020$12,629,000
+33.7%
57,500
+1.1%
0.02%
-26.7%
Q3 2020$9,448,000
+66.8%
56,900
+14.7%
0.03%
+15.4%
Q2 2020$5,663,000
+3.6%
49,600
-30.2%
0.03%
-40.9%
Q1 2020$5,465,000
-30.1%
71,100
+17.1%
0.04%
-17.0%
Q4 2019$7,822,000
-51.3%
60,700
-70.6%
0.05%
-59.2%
Q3 2019$16,073,000
+53.0%
206,300
+102.3%
0.13%
+36.8%
Q2 2019$10,506,000
+14291.8%
102,000
+10100.0%
0.10%
+9400.0%
Q1 2019$73,000
-88.7%
1,000
-92.7%
0.00%
-80.0%
Q3 2018$645,000
+335.8%
13,700
+356.7%
0.01%
+400.0%
Q2 2018$148,000
-50.3%
3,000
-69.1%
0.00%
-66.7%
Q1 2018$298,000
+72.3%
9,700
+2.1%
0.00%
+200.0%
Q4 2017$173,000
+55.9%
9,5000.0%0.00%0.0%
Q3 2017$111,000
+226.5%
9,500
+850.0%
0.00%
Q3 2015$34,000
-87.0%
1,000
-88.0%
0.00%
-100.0%
Q2 2015$261,0008,3000.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING LLC 49,400$1,836,6920.01%
SIMPLEX TRADING, LLC 37,300$1,3860.00%
JANE STREET GROUP, LLC 5,700$211,9260.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of MIRATI THERAPEUTICS INC shareholders